Effect of Dapagliflozin Plus Low Dose Pioglitazone on Hospitalization Rate in Patients With HF and HFpEF

NCT03794518 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

648

Enrollment

INDUSTRY

Sponsor class

Conditions

Risk Reduction

Interventions

DRUG: Pioglitazone Plus dapaglifliozin
DRUG: Placebo

Sponsor

Hamad Medical Corporation